Literature DB >> 2474516

Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies.

M Kuroki1, J W Greiner, J F Simpson, F J Primus, F Guadagni, J Schlom.   

Abstract

A series of 14 monoclonal anti-carcinoembryonic antigen (CEA, Mr 180,000) antibodies (MAbs) that show a strong degree of selective reactivity for human colon carcinomas versus normal adult tissues were used to construct a serological map of the CEA molecule. The MAbs were generated using extracts of colon carcinomas as immunogen and are thus given a COL designation. None of the 14 COL-MAbs tested were reactive with purified non-specific cross-reacting antigen (NCA, Mr 55,000) from normal lung, although some showed reactivity to human granulocytes. All the COL-MAbs tested were reactive with normal fecal antigen-2 (NFA-2, Mr 170,000); however, many of the COL-MAbs demonstrated a higher affinity constant to CEA than to NFA-2. Cross-competition radioimmunoassays classified the 14 COL-MAbs into 5 groups. The chemical nature of the COL-binding domains was tested using chemically or enzymatically treated CEA; all reacted with periodate-treated CEA and deglycosylated CEA, indicating that the COL-reactive epitopes appear to be of a proteinaceous nature. Heat treatment, reduction, alkylation, pepsin digestion or pronase treatment of CEA, however, gave differential results with respect to COL binding. Antibody titration experiments were carried out to define differential reactivities to colorectal carcinoma versus NCA-containing granulocyte extracts; these results were compared with results obtained using several anti-CEA MAbs that have been used in clinical trials. Granulocyte binding and biochemical studies showed that the COL MAbs may distinguish as many as 7 to 10 CEA epitopes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474516     DOI: 10.1002/ijc.2910440204

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Targeting antibodies to live tumor tissue in 3-D histoculture.

Authors:  F Guadagni; L Li; R M Hoffman
Journal:  In Vitro Cell Dev Biol       Date:  1992-05

2.  Measurement of mass transport and reaction parameters in bulk solution using photobleaching. Reaction limited binding regime.

Authors:  E N Kaufman; R K Jain
Journal:  Biophys J       Date:  1991-09       Impact factor: 4.033

3.  Conjugates of COL-1 monoclonal antibody and beta-D-galactosidase can specifically kill tumor cells by generation of 5-fluorouridine from the prodrug beta-D-galactosyl-5-fluorouridine.

Authors:  R Abraham; N Aman; R von Borstel; M Darsley; B Kamireddy; J Kenten; G Morris; R Titmas
Journal:  Cell Biophys       Date:  1994

4.  Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant.

Authors:  P H Hand; B Calvo; D Milenic; T Yokota; M Finch; P Snoy; K Garmestani; O Gansow; J Schlom; S V Kashmiri
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.

Authors:  X Fu; F Guadagni; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

6.  Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.

Authors:  K Irvine; J Schlom
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

7.  Epitopes predominantly retained on the carcinoembryonic antigen molecules in plasma of patients with malignant tumors but not on those in plasma of normal individuals.

Authors:  M Kuroki; M Murakami; M Wakisaka; A Krop-Watorek; S Oikawa; H Nakazato; G Kosaki; Y Matsuoka
Journal:  Jpn J Cancer Res       Date:  1992-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.